Literature DB >> 27743123

Effect of comorbidities on postoperative complications in patients with gastric cancer after laparoscopy-assisted total gastrectomy: results from an 8-year experience at a large-scale single center.

Jia-Bin Wang1, Chao-Hui Zheng1, Ping Li1, Jian-Wei Xie1, Jian-Xian Lin1, Jun Lu1, Qi-Yue Chen1, Long-Long Cao1, Mi Lin1, Chang-Ming Huang2.   

Abstract

BACKGROUND: Comorbidity is a predictor of postoperative complications in gastrectomy. However, it remains unclear which comorbidities are predictors of postoperative complications in gastric cancer patients who have undergone laparoscopy-assisted total gastrectomy (LATG). The purpose of this study was to evaluate the effect of comorbidities on the surgical outcomes of patients with gastric cancer after LATG.
METHODS: We retrospectively collected data on 1657 gastric cancer patients who underwent LATG between January 2008 and December 2015. We investigated the incidences, types, and risk factors for postoperative complications after LATG. Patients were enrolled in analysis to evaluate the effects of comorbidities on postoperative complications.
RESULTS: The number of postoperative complications was associated with the number of comorbidities in the gastric cancer patients according to the operative period. Of the 1657 patients included in this study, 714 (43.1 %) had one or more comorbidities. Postoperative complications occurred in 283 patients (17.1 %), and 6 patients (0.4 %) died during hospitalization. With an increasing number of comorbidities, the incidence of local and systemic complications also increased. Univariate and multivariate analyses revealed that comorbidity was a predictive risk factor for local complications (OR 1.204, 1.014-1.431) and systemic complications (OR 1.237, 1.039-1.474). Diabetes mellitus, anemia, pulmonary disease, and renal dysfunction were found to be associated with postoperative complications, including abdominal bleeding, anastomotic leakage, and pneumonia.
CONCLUSIONS: Our study has revealed that comorbidities could be a predictive risk factor for postoperative complications after LATG. Surgeons should carefully assess patients with full perioperative attention to some specific types of comorbidities.

Entities:  

Keywords:  Complications; Gastrectomy; Gastric cancer; Laparoscopy

Mesh:

Year:  2016        PMID: 27743123     DOI: 10.1007/s00464-016-5279-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  24 in total

Review 1.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.

Authors:  Paul A Carless; David A Henry; Jeffrey L Carson; Paul Pc Hebert; Brian McClelland; Katharine Ker
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

2.  Does preoperative anemia adversely affect colon and rectal surgery outcomes?

Authors:  Stefan W Leichtle; Nicolas J Mouawad; Richard Lampman; Bonita Singal; Robert K Cleary
Journal:  J Am Coll Surg       Date:  2011-02       Impact factor: 6.113

3.  Blood management by transfusion triggers: when less is more.

Authors:  Sana Ansari; Arpad Szallasi
Journal:  Blood Transfus       Date:  2011-06-15       Impact factor: 3.443

Review 4.  Huang's three-step maneuver for laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer.

Authors:  Chang-Ming Huang; Qi-Yue Chen; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie
Journal:  Chin J Cancer Res       Date:  2014-04       Impact factor: 5.087

5.  Gastric cancer in patients above 70 years of age.

Authors:  T Oohara; Y Johjima; O Yamamoto; H Tohma; Y Kondo
Journal:  World J Surg       Date:  1984-06       Impact factor: 3.352

6.  Incidence of and risk factors for pulmonary complications after nonthoracic surgery.

Authors:  Finlay A McAlister; Kimberly Bertsch; Jeremy Man; John Bradley; Michael Jacka
Journal:  Am J Respir Crit Care Med       Date:  2004-11-24       Impact factor: 21.405

7.  Laparoscopy-assisted distal gastrectomy for gastric cancer patients with comorbid diseases: is it contraindicated for patients with systemic comorbidity?

Authors:  Yoo Shin Choi; Do Joong Park; Hyuk-Joon Lee; Hyung-Ho Kim; Han-Kwang Yang; Kuhn Uk Lee
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2011-02       Impact factor: 1.719

8.  Perioperative risk assessment for gastrectomy by surgical apgar score.

Authors:  Yuichiro Miki; Masanori Tokunaga; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  Ann Surg Oncol       Date:  2014-03-25       Impact factor: 5.344

9.  Laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer in left approach: a new operation procedure.

Authors:  Wang Jia-Bin; Huang Chang-Ming; Zheng Chao-Hui; Li Ping; Xie Jian-Wei; Lin Jian-Xian
Journal:  World J Surg Oncol       Date:  2012-11-12       Impact factor: 2.754

10.  Why the Proximal Splenic Artery Approach is the Ideal Approach for Laparoscopic Suprapancreatic Lymph Node Dissection in Advanced Gastric Cancer? A Large-Scale Vascular-Anatomical-Based Study.

Authors:  Rui-Fu Chen; Chang-Ming Huang; Qi-Yue Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

View more
  8 in total

1.  Desmopressin acetate decreases blood loss in patients with massive hemorrhage undergoing gastrointestinal surgery.

Authors:  Li-Chun Wang; Ying-Fang Hu; Lei Chen; Rui Xing; Xin-Feng Lin; Qiu-Ye Kou
Journal:  Turk J Gastroenterol       Date:  2020-06       Impact factor: 1.852

2.  Sleeve Gastrectomy Postoperative Hemorrhage is Linked to Type-2 Diabetes and Not to Surgical Technique.

Authors:  Hadar Spivak; Carmil Azran; Galia Spectre; Galina Lidermann; Orit Blumenfeld
Journal:  Obes Surg       Date:  2017-11       Impact factor: 4.129

3.  Association of Diabetes Mellitus With Postoperative Complications and Mortality After Non-Cardiac Surgery: A Meta-Analysis and Systematic Review.

Authors:  Xiaoying Zhang; Aisheng Hou; Jiangbei Cao; Yanhong Liu; Jingsheng Lou; Hao Li; Yulong Ma; Yuxiang Song; Weidong Mi; Jing Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-26       Impact factor: 6.055

4.  Jejunal Mesentery Preservation Reduces Leakage at Esophagojejunostomy After Minimally Invasive Total Gastrectomy for Gastric Cancer: a Propensity Score-Matched Cohort Study.

Authors:  Naoshi Kubo; Katsunobu Sakurai; Yutaka Tamamori; Tsuyoshi Hasegawa; Shuhei Kushiyama; Kenji Kuroda; Akihiro Murata; Shintaro Kodai; Takafumi Nishii; Akiko Tachimori; Sadatoshi Shimizu; Akishige Kanazawa; Toru Inoue; Kiyoshi Maeda; Yukio Nishiguchi
Journal:  J Gastrointest Surg       Date:  2022-10-24       Impact factor: 3.267

5.  Comparison of short-term and long-term efficacy of laparoscopic and open gastrectomy in high-risk patients with gastric cancer: a propensity score-matching analysis.

Authors:  Bin-Bin Xu; Jun Lu; Zhi-Fang Zheng; Chang-Ming Huang; Chao-Hui Zheng; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ping Li; Ju-Li Lin
Journal:  Surg Endosc       Date:  2018-06-21       Impact factor: 4.584

6.  Impact of Various Types of Comorbidities on the Outcomes of Laparoscopic Total Gastrectomy in Patients with Gastric Carcinoma.

Authors:  Oh Jeong; Mi Ran Jung; Seong Yeob Ryu
Journal:  J Gastric Cancer       Date:  2018-09-10       Impact factor: 3.720

7.  Laparoscopic gastrectomy for elderly gastric-cancer patients: comparisons with laparoscopic gastrectomy in non-elderly patients and open gastrectomy in the elderly.

Authors:  Zheng-Yan Li; Jie Chen; Bin Bai; Shuai Xu; Dan Song; Bo Lian; Ji-Peng Li; Gang Ji; Qing-Chuan Zhao
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-09-10

8.  Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score.

Authors:  Yeongkeun Kwon; Jin-Won Kwon; Jane Ha; Dohyang Kim; Jaehyeong Cho; Soo Min Jeon; Shin-Hoo Park; Jinseub Hwang; Nam Hoon Kim; Sungsoo Park
Journal:  Gastric Cancer       Date:  2021-07-22       Impact factor: 7.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.